Application of Chitosan-Based Gels in Pharmaceuticals - Chitosan Based Hydrogels: Functions and Applications - page 331

50. Kang, M. L., Kang, S. G., Jiang, H. L., Shin, S. W., Lee, D. Y., Ahn, J. M., Rayamahji, N. et al.
2006. In vivo induction of mucosal immune responses by intranasal administration of chito-
san microspheres containing Bordetella bronchiseptica DNT. Eur J Pharm Biopharm 63:
215-220.
51. Jiang, H. L., Park, I. K., Shin, N. R., Kang, S. G., Yoo, H. S., Kim, S. I., Suh, S. B., Akaike, T., and
Cho, C. S. 2004. In vitro study of the immune stimulating activity of an athrophic rhinitis vac-
cine associated to chitosan microspheres. Eur J Pharm Biopharm 58: 471-476.
52. Jaganathan, K. S., Rao, Y. U. B., Singh, P., Prabakaran, D., Gupta, S., Jain, A., and Vyas, S. P. 2005.
Development of a single dose tetanus toxoid formulation based on polymeric microspheres:
A comparative study of poly(d, l-lactic- co -glycolic acid) versus chitosan microspheres. Int
J Pharm 294: 23-32.
53. Mi, F. L., Shyu, S. S., Chen, C. T., and Schoung, J. Y. 1999. Porous chitosan microsphere for con-
trolling the antigen release of Newcastle disease vaccine: Preparation of antigen-adsorbed
microsphere and in vitro release. Biomaterials 20: 1603-1612.
54. Zhao, H. P., Wu, B., Wu, H., Su, L. Y., Pang, J. L., Yang, T. H., and Liu, Y. L. 2006. Protective
immunity in rats by intranasal immunization with Streptococcus mutans glucan-binding protein
D encapsulated into chitosan-coated poly(lactic- co -glycolic acid) microspheres. Biotechnol Lett
28: 1299-1304.
55. Lameiro, M. H., Malpique, R., Silva, A. C., Alves, P. M., and Melo, E. 2006. Encapsulation of
adenoviral vectors into chitosan-bile salt microparticles for mucosal vaccination. J Biotechnol
126: 152-162.
56. Van der Lubben, I. M., Konings, F. A. J., Borchard, G., Verhoef, J. C., and Junginger, H. E. 2001.
In vivo uptake of chitosan microparticles by murine Peyer's patches: Visualization studies using
confocal laser scanning microscopy and immunohistochemistry. J Drug Target 9: 39-47.
57. Van der Lubben, I. M., Van Opdorp, F. A. C., Hengeveld, M. R., Onderwater, J. J. M., Koerten, H.
K., Verhoef, J. C., Borchard, G., and Junginger, H. E. 2002.Transport of chitosan microparticles for
mucosal vaccine delivery in a human intestinal M-cell model. J Drug Target 10: 449-456.
58. Oie, S. and Benet, L. Z. 1996. The effect of route of administration and distribution on drug
action. In Modern Pharmaceutics , G. S. Banker and C. T. Rhodes, eds. New York, NY: Marcel
Dekker, 155-178.
59. Buri, P. 1985. Voie oral. In Formes pharmaceutiques nouvelles : aspects technologique, biophar-
maceutique et medical, eds. P. Buri, F. Puisieux, E. Doelker, J. P. Benoit. Paris: Technique et
documentation (Lavoisier) 175-228.
60. Hejazi, R. and Amiji, M. 2004. Stomach-specific anti- H-pylori therapy Part III: Effect of chitosan
microspheres cross-linking on the gastric residence and local tetracycline concentrations in
fasted gerbils. Int J Pharm 272: 99-108.
61. El-Gibaly, I. 2002. Development and in vitro evaluation of novel floating chitosan microcapsules
for oral use: Comparison with non-floating chitosan microspheres. Int J Pharm 249: 7-21.
62. Hejazi, R. and Amiji, M. 2002. Stomach-specific anti- H-pylori therapy. 1: Preparation and char-
acterization of tetracyline-loaded chitosan microspheres. Int J Pharm 235: 87-94.
63. Portero, A., Remunan-Lopez, C., Criado, M. T., and Alonso, M. J. 2002. Reacetylated chitosan
microspheres for controlled delivery of anti-microbial agents to the gastric mucosa.
J Microencapsul 19: 797-809.
64. Tozaki, H., Komoike, J., Tada, C., Maruyama, T., Terabe, A., Suzuki, T., Yamamoto, A., and
Muranishi, S. 1997. Chitosan capsules for colon-specific drug delivery: Improvement of insulin
absorption from the rat colon. J Pharm Sci 86: 1016-1021.
65. Pantaleone, D. et al. 1991. Advances in chitin and chitosan. In Fifth International Conference on
Chitin and Chitosan . Princeton, New York, NY.
66. Zhang, H., Alsarra, I. A., and Neau, S. H. 2002. An in vitro evaluation of a chitosan-containing
multiparticulate system for macromolecule delivery to the colon. Int J Pharm 239: 197-205.
67. Tominaga, S. et al. 1998. Colon drug delivery system. J Pol Appl JP 10 324, 642 (98324,642) (C1
A61K47/36).